Congratulations to ThinkGenetic Advocacy Partner, cureCADASIL, who received a donation of $500 from ThinkGenetic. The donation amount was based on converted ThinkPoints, which ThinkGenetic users accrued in August 2017. The… CONTINUE
ThinkGenetic Announces Deepti Babu, MS, CGC as Vice President of Communications and Patient Advocacy
ThinkGenetic is happy to announce the hire of certified genetic counselor and medical writer, Deepti Babu, to Vice President of Communications and Patient Advocacy. She will have the primary responsibility… CONTINUE
Visionary Greg Grabowski, MD Joins ThinkGenetic’s Board of Directors
ThinkGenetic, Inc., a provider of direction for those living with genetic diseases, today announced that human genetics visionary and successful biotech leader Greg Grabowski, MD has joined its Board. ThinkGenetic,… CONTINUE
A Very Special Audience: The Pope Focuses Attention on Huntington’s Disease and Rare Genetic Conditions
Too often, due to a complex combination of fear, stigma, financial, and family implications, individuals affected by devastating rare genetic conditions like Huntington’s disease have been marginalized and misunderstood. Today,… CONTINUE
Care Day for Hereditary ATTR Amyloidosis in Iowa
Join us for a live Care Day Event in Iowa City sponsored by Alnylam Pharmaceuticals presented in partnership with ThinkGenetic. Come learn about topics relating to hATTR amyloidosis including: Disease overview… CONTINUE
TRNDS Panel: Virtual Visits to Facilitate the Conduct of Feasible Clinical Trials
ThinkGenetic CEO and Founder, Dave Jacob, will be a part of an impressive panel this week, discussing ways in which technology can help to facilitate clinical trials participation. The Technology &… CONTINUE
How Genetic Disease Families Push Through, Move Forward and Find Answers
Such a sentiment is lived by the millions of individuals and families around the world who go through the genetic condition diagnostic odyssey. Search the news section on any rare… CONTINUE
How a Social Post Forged a Partnership with HCU Network America
After highlighting Homocystinuria, an inherited disorder where the body is unable to process some of the building blocks of the body, in the Genetic Condition of the Day campaign, ThinkGenetic… CONTINUE
Peter Wilkerson Promoted to ThinkGenetic Vice President, Application Design and Development
ThinkGenetic, Inc. is excited to announce the promotion of Peter Wilkerson to Vice President, Application Design and Development. In his new role Peter will continue designing and developing applications which… CONTINUE
Davalen Spawns ThinkGenetic and Exits the Consulting Services Market
After 10 years as an IBM premier partner of consulting services in the collaborative solutions market, the Davalen LLC team has moved on to helping people living with genetic conditions. … CONTINUE
ThinkGenetic in 2016: A Message from the President
Preparing for this article on a year in the life of ThinkGenetic required the collection of statistics about financial and content contributors, website visitors, research and development activities, and partner… CONTINUE
ThinkGenetic Signs First International Advocacy Partner
France based support group, Cutis Laxa Internationale, becomes first International ThinkGenetic Advocacy Partner Cutis Laxa Internationale became an official ThinkGenetic Advocacy Partner today, the first advocacy partner based outside the… CONTINUE
Lynch Syndrome Patients Receive V.P. Biden’s Attention
Cancer Moonshot is a new initiative led by Vice President Joe Biden that aims to make additional therapies available to more patients, while also improving prevention and early detection. The program,… CONTINUE
First International SYNGAP1 Conference and Bridge the Gap – SYNGAP ERF
As ThinkGenetic outreach coordinators so much of what we do includes hearing the stories of those with genetic conditions and meeting incredible advocates. One such person our team recently met was Monica Weldon,… CONTINUE
ThinkGenetic to Sponsor 2016 USC Genetic Counseling Fall Symposium on November 11
ThinkGenetic is very excited to be a sponsor at the upcoming 2016 Genetic Counseling Fall Symposium in Columbia, South Carolina on November 11, 2016. Focusing on the needs of genetic counselors, geneticists,… CONTINUE
From Submarines to Genetic Diseases, Finding Answers Across the Decades
The year is 1983. I had just finished Navy Nuclear Power School, Ronald Reagan was president and the fledgling National Organization for Rare Disorders (NORD) helped pass the Orphan Drug… CONTINUE
ThinkGenetic Extends Handshake to the National Gaucher Foundation
Advocacy Partnership Leads to Increased Awareness and Future Contributions for Gaucher Disease In a show of support, the National Gaucher Foundation (NGF) has entered into an advocacy partnership agreement with… CONTINUE
Protected: ThinkGenetic Continues to Shorten Time to Diagnosis with Help from Alexion Pharmaceuticals
There is no excerpt because this is a protected post.
Laney Recruits Genetic Counselors to Help Fix Genetic Information on the Internet
For nearly twenty years, genetic counselor Dawn Jacob Laney, MS, CGC, CCRC, has scoured the internet for information related to her passion – genetic diseases and disorders. Her first foray… CONTINUE
Why My Kindred Spirit is a Rock Star
At first glance, it may not seem Austin Carlile, the front-man of the metal-core band Of Mice & Men and I have much in common. We grew up about 100… CONTINUE
6th Annual Fabry Family Medical Conference
On September 8-9, 2016 in Greensboro, North Carolina the National Fabry Disease Foundation (NFDF) will be hosting it’s annual Fabry Family Medical Conference. An important event for all individuals with Fabry disease… CONTINUE
ThinkGenetic Joins Forces with C22C
ThinkGenetic is pleased to announce the advocacy partnership with Chromosome 22 Central, Inc., also known as C22C. Chromosome 22 Central is a parent powered support organization founded in 1997 to… CONTINUE
Commissioning IBM Watson™ for Genetic Disease
Sometimes your next business adventure comes from the most unlikely of situations. Like many small business owners, Len Barker found himself diving into a new pool of opportunity after being… CONTINUE
New Partnership with Genetic Alliance Helps Expands Healthcare Resources for Genetic Disease Patients Online
Largest Non-Profit Genetic Health Advocacy Organization, Genetic Alliance, Joins in Partnership with ThinkGenetic to Empower Patients In a time when “genetics”, “genomes”, and “genes” are becoming a daily topic of… CONTINUE
ThinkGenetic Father Hopes to Revolutionize Genetic Information on the Internet
Like many other people with a genetic disease, Dave Jacob did not learn that his childhood heart defect was related to an underlying genetic mutation until it was uncovered he… CONTINUE
ThinkGenetic is Open for Individual Pledges on Kickstarter for 30 Days
For the next thirty days, ThinkGenetic is offering a chance for our champions and advocates to support the project on Kickstarter! That’s right, for as little as $25 you can… CONTINUE
Frequently Asked Questions: How Can Parents Be Involved?
As we spread the news about ThinkGenetic we love to chat with the community and answer any questions about our exciting site. As these questions come in we like to share… CONTINUE
ThinkGenetic Founder, Dawn Laney, to be honored at 2016 Rare Impact Awards on May 17th
Coming this May, NORD is hosting the 2016 Rare Impact Awards to bring together the rare disease community and to honor and celebrate outstanding achievements. During the event NORD will recognize the… CONTINUE
Video: Why ThinkGenetic is the Best New Innovation in Pediatric Healthcare
ThinkGenetic is a labor of love between ThinkGenetic, Inc., Emory University’s Department of Human Genetics and IBM. Supported by International Advocacy groups like The Legacy of Angels, NORD and Genetic… CONTINUE
ThinkGenetic to Exhibit with Emory Genetics Laboratory at WORLDSymposium™
ThinkGenetic, Inc., is proud to be exhibiting alongside Emory Genetics Laboratory at the Manchester Grand Hyatt San Diego the week of February 29 – March 4, 2016 to demonstrate the beta of ThinkGenetic. This… CONTINUE